Ergothioneine COA Review: How to Verify 99% HPLC, Identity and Lot Release

Quick Answer

99% Ergothioneine is not a complete release specification. It is only a starting point.

For a buyer qualifying a cosmetic or specialty-ingredient lot, the COA must answer several separate questions: Is the material actually Ergothioneine? What does the 99% number measure? Is it reported on an as-is or dried basis? Does the method distinguish the target from related substances? Does the document belong to the shipped lot? Can the supplier's identity and process evidence support the grade being offered?

Current marketplace listings use similar language for materially different products. A defined high-purity L-Ergothioneine powder may show a chromatographic assay, while a mushroom extract may report Ergothioneine as a marker constituent within a broader matrix. The two COAs should not be reviewed with the same checklist. The practical sequence is:

material identity → material architecture → assay definition → method and standard → related substances → moisture and residue → microbiology and contaminants → lot traceability → release decision

What a 99% Result Does and Does Not Tell You

A result written as 99% HPLC is incomplete until the supplier defines the field. It may refer to an assay calculated against a reference standard, chromatographic area normalization, or another method-specific expression. Those results can look numerically identical while representing different measurements.

Ask the supplier to identify:

• the exact name of the test
• the chromatographic method and detector
• the reference standard and its assigned value
• the calculation basis
• whether the result is as-is, dry basis or corrected for water
• the acceptance limit and the actual lot result
• whether the method covers related Ergothioneine compounds or only the principal peak

Do not convert a supplier headline into a stronger claim. 99% HPLC is not automatically 99% w/w isolated L-Ergothioneine, 99% assay on a dry basis, 99% purity by mass balance, or proof that the remaining 1% contains no process-relevant substances. This is a method-definition issue, not a criticism of a particular supplier. A legitimate method can be useful for release while still requiring exact interpretation before suppliers are compared.

Confirm the Material Identity Before Reviewing the Number

Ergothioneine and L-Ergothioneine are commonly associated with CAS 497-30-3 and molecular formula C9H15N3O2S. The CAS number is a useful identity anchor, but it does not prove that the powder inside a shipment matches the label. The COA should connect the lot to a controlled product name, internal material code, CAS number and batch number. The product name should be consistent with the specification, packing label, invoice and RFQ response. If one document says mushroom extract and another says 99% L-Ergothioneine, resolve the difference before approval.

For a defined high-purity grade, request an identity test in addition to the assay result. Evidence may include a chromatographic retention-time match, spectral comparison, or another validated approach. Identity and quantity are separate fields. For a standardized mushroom extract, the identity package must go further. Request the mushroom species or biological source, extract ratio or preparation description, carrier information, marker definition and the method used to quantify Ergothioneine. The marker result does not describe the entire extract matrix.

Published mushroom research shows that Ergothioneine content varies with species, maturity and growing conditions.[1] A supplier cannot therefore replace source and process information with the single statement mushroom derived.

Decide Whether the COA Is for a Defined Chemical or an Extract

For a high-purity defined L-Ergothioneine powder, the main COA questions concern identity, assay, related substances, water, residue and process-specific contaminants. A result near 99% may be commercially meaningful, but only if the method and basis are understood. For a 0.5% or 1% mushroom extract, the Ergothioneine value is generally a marker or standardization field. The other material is not automatically an unwanted impurity. It may include the intended mushroom-derived matrix, extraction solids, moisture and declared carrier. The COA should control that matrix according to the product's intended use.

The release decision must follow the material's specification. Do not reject an extract because it does not resemble a high-purity chemical COA, or approve a 99% powder merely because its headline percentage is higher than an extract's marker value.

Review the Assay Method, Not Only the Result

When a supplier says HPLC, ask what the method actually separates and detects. The buyer may not need the complete analytical SOP at first inquiry, but should request enough information to understand selectivity, standardization and calculation. The method review should cover:

• column and mobile-phase system, where disclosure is available
• detection wavelength or detector type
• reference standard identity and purity assignment
• sample preparation and dilution
• system suitability or relevant performance checks
• retention time or identification criterion
• reporting unit and calculation basis
• actual result and specification limit

ICH Q2(R2) provides a useful framework for thinking about analytical procedure validation, including specificity, accuracy, precision, range and robustness.[2] It is not a universal cosmetic COA template, but it helps the buyer ask whether the method is fit for the claim being made. A method that measures the principal Ergothioneine peak may be adequate for a defined release test, yet insufficient to answer a separate question about D- and L-form composition or trace related substances. Do not force one test to answer every question.

Treat L-Form Evidence as a Separate Identity Question

The L form is commercially important because suppliers often describe the material as L-Ergothioneine or L-(+)-Ergothioneine. A high assay result does not automatically establish stereochemical identity. Depending on the intended specification, supporting evidence may include optical rotation, an enantioselective chromatographic method, or a validated identity package that the supplier can explain. A published safety evaluation of nature-identical L-Ergothioneine included chromatographic characterization and optical rotation as part of the test-substance description.[3]

More recent analytical work has shown that D- and L-Ergothioneine can be separated using an enantio-selective LC-MS/MS approach.[4] It shows why 99% HPLC and confirmed L-Ergothioneine should not be collapsed into one statement when the specification depends on the L form. The RFQ should therefore state whether L-form evidence is required, what evidence is acceptable, and whether the requirement applies to every lot or only to initial qualification.

Check Moisture, Residue and the Basis of Comparison

Two COAs may show the same assay result but different actual active loads if one result is reported as-is and the other on a dried basis. Water, loss on drying and residual solvent fields should be read alongside the assay, not as unrelated administrative data. For a powder, ask whether the specification controls water content, loss on drying, residue on ignition or another measure of non-volatile material. The applicable test depends on the material and method. Do not treat a missing field as proof of failure, but do treat it as an unresolved comparison point.

For a mushroom extract, moisture can affect marker concentration and handling. A marker result without a defined basis is difficult to compare between lots. Request the calculation basis and a representative lot COA before setting an acceptance limit. If active-equivalent cost is being calculated, use the same basis for every candidate. A nominal 99% result on an as-is basis is not directly comparable with a 99% result corrected for water unless the calculation is normalized.

Separate Related Substances from Total Purity

Purity may be used as a broad commercial label, while related substances, residual reagents, residual solvents, inorganic residue and trace metals are separate quality questions. For a defined high-purity material, ask which process-relevant impurities are controlled and whether the current specification includes actual limits. The route of manufacture changes the questions. Extraction can leave matrix or solvent-related concerns; fermentation can create broth-derived or process-related residues; chemical synthesis can require a different residual and related-substance review.[5]

Do Not Overlook Microbiology and Contaminant Controls

For a mushroom extract or a material intended for a product with microbiological sensitivity, review total plate count, yeast and mold, specified pathogens, heavy metals and any market-specific contaminant requirements included in the controlled specification. For a high-purity chemical powder, the same fields may still matter depending on use, packaging and destination market. Their absence is not automatically a defect, but document why the field is not required or request it before release.

Verify That the COA Belongs to the Shipment

Do not accept a sample COA as if it were a lot-release document.

Before approval, match the COA to:

• supplier legal name and manufacturing site
• product name and internal code
• batch or lot number
• manufacturing date and retest or expiry date
• quantity and package configuration
• test date and release date
• authorized signatory or quality-system identifier
• label and outer packaging

If the supplier sends a blank template or an undated typical COA, classify it as specification evidence, not shipment release evidence. Ask for a current lot COA and, before purchase, the shipment lot document where possible. Do not demand a generic impurity list copied from another ingredient. Ask the supplier to identify controls relevant to the offered route and grade. A higher HPLC number does not prove low chloride, low ash, low residual solvent or absence of trace contaminants.

Current Sourcing Candidates

The following candidates are discovery inputs for this article. They are listed in order of appearance, not ranked.

Use a Release Decision Rather Than a Score Alone

The COA review should end with a documented decision:

• Accept — identity, assay basis, lot traceability and required quality fields are consistent with the approved specification.
• Accept with clarification — the material appears technically suitable, but a non-critical field or calculation basis must be confirmed before final release.
• Hold — the lot may be usable, but identity, method, batch linkage or a required result is incomplete.
• Reject — the product identity conflicts with the specification, the lot cannot be traced, or a required acceptance criterion fails.

This structure prevents a high assay number from overriding a missing lot number or unresolved identity conflict.

These pages are sourcing leads, not evidence that any lot has passed Ingredexa release criteria. Before purchase, request the current specification, lot COA, method description, L-form evidence where required, packaging details and manufacturer information. Supplier age is a stability signal, not a substitute for technical documentation. No a supplier storefront option is included without a separately verified supplier homepage.

RFQ Wording That Prevents a Weak COA

Ask the supplier to quote against the following points:

• exact material name and CAS
• defined powder or mushroom extract architecture
• assay name, method, reference standard and calculation basis
• as-is or dry-basis reporting
• identity method
• L-form or optical-rotation evidence, if required
• water or loss on drying
• related substances and route-relevant residual controls
• microbiological and contaminant limits where applicable
• batch number, test date, release date and retest period
• packaging, storage and transport conditions
• current lot COA rather than only a typical certificate

If the supplier cannot explain what 99% HPLC means, the percentage is not ready for direct comparison.

Buyer Decision

An Ergothioneine COA is useful only when the number is tied to a defined material, a known method and a traceable lot. For high-purity L-Ergothioneine, confirm identity, assay basis, method selectivity, L-form evidence, moisture, related substances and lot release. For mushroom extract, add biological source, matrix, marker definition and extract controls. In both cases, keep supplier claims, analytical results and buyer interpretation separate. The release decision should be made from the complete evidence package, not from the largest percentage printed on the first page.

References

1. Dubost NJ, et al. Identification and quantification of ergothioneine in cultivated mushrooms. International Journal of Medicinal Mushrooms. 2006.
2. ICH. Q2(R2) Validation of Analytical Procedures. International Council for Harmonisation. 2023.
3. Marone PA, et al. A Safety Evaluation of a Nature-Identical L-Ergothioneine in Sprague Dawley Rats. International Journal of Toxicology. 2016. doi:10.1177/1091581816653375.
4. Enantio-selective analytical method for ergothioneine using chemical tagging coupled with LC-MS/MS and D/L ratio measurements in mushrooms. Journal of Pharmaceutical and Biomedical Analysis Open. 2026;7:100103.
5. Sato S, Saika A, Koshiyama T, et al. Biosynthesis of ergothioneine: current state, achievements, and perspectives. Applied Microbiology and Biotechnology. 2025;109:93. doi:10.1007/s00253-025-13476-4.